Crop Protection

ADAMA’s Gilboa™ Recognized with Unique Mode of Action for Cereal Crops by FRAC

ADAMA projects revenues for full-year 2024 to decline by 7% to 16% in USD, amounting to $3,934 million to $4,348 million.

Key Takeaways

  • ADAMA‘s Gilboa™ has been classified by FRAC as having a unique mode of action, Group 32, targeting nucleic acid metabolism.
  • The new active ingredient offers protection against key cereal and oilseed rape diseases, including Septoria and Sclerotinia.
  • Gilboa™ introduces an alternative tool for resistance management in cereals, where resistance to existing fungicide chemistries is rising.
  • Field trials showed extended disease control and improved yield indicators.
  • ADAMA expects regulatory approval in Great Britain by 2027 and in the EU by 2029.

ADAMA receives FRAC recognition for Gilboa™’s novel mode of action

ADAMA Ltd. (Profile) has announced that its new active ingredient Gilboa™ has been classified by the Fungicide Resistance Action Committee (FRAC) as having a unique mode of action for cereal crops. Grouped under Group 32, Gilboa™ targets nucleic acid metabolism — a biochemical pathway not previously used by fungicides in cereals.

“Gilboa represents a major step forward in fungicide innovation, providing growers with an entirely new way to combat fungal pathogens in cereals,” said Florian Wagner, EVP Portfolio and Innovation at ADAMA.


Alternative solutions to growing resistance challenges

Fungal diseases such as Septoria have shown increasing resistance to existing fungicide modes of action. Gilboa™ aims to offer growers an alternative solution, helping secure crop yields and maintain crop health.

Alex Mills, Head of Global Fungicides at ADAMA, commented, “Gilboa is a game-changer for European farmers. By expanding the available fungicide options, Gilboa helps ensure reliable disease control while reducing the risk of resistance development.”

Gilboa™ is compatible with existing fungicides, allowing for integration into current disease management programs.


Trial results demonstrate extended control and yield benefits

Since its development, ADAMA has conducted extensive trials of Gilboa™ across multiple regions and conditions. Trial data highlights include:

Gilboa™ Trial Results Summary

Performance Measure Result
Disease control Up to 35 days after final application
Green leaf retention Over 70% of flag leaf area stayed green post-treatment
Yield potential Extended protection contributed to higher yields

The active ingredient, flumetylsulforim, was shown to outperform existing solutions in a significant number of wheat Septoria trials.


ADAMA’s Regulatory and market rollout planned

Gilboa™ was submitted for registration in 2023 and is on track for approval in Great Britain in 2027 and in the European Union in 2029. Additional registrations are planned for other markets.

Field demonstrations will be held in the UK during June 2025, offering growers and industry representatives the opportunity to observe Gilboa™’s performance in practical settings.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

2 Comments

  • […] capital costs. Business unit performance varied, with Syngenta Seeds showing growth of 9% while ADAMA sales decreased by 15%. Despite mixed results, Syngenta continues to focus on productivity […]

  • AgTech Highlights 10th November 2024

    […] Ltd. has opened a chloralkali production facility, designed to enhance fungicide production by increasing chlorine supply for products like Captan […]

Leave a Reply